cGVHD Clinical Trial
Official title:
Study on the Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease (cGVHD) of the Liver Following Allogeneic Hematopoietic Stem Cell Transplantatio
The study plan aims to include patients who have been diagnosed with steroid-refractory chronic GVHD in the liver following allogeneic hematopoietic stem cell transplantation. After obtaining informed consent, the patients will be randomly assigned to either the Anti-CD25 rhMAb treatment group or the traditional treatment group. The objective is to assess the effectiveness and safety of Anti-CD25 rhMAb in the treatment of severe chronic GVHD affecting the liver.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01221766 -
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
|
N/A | |
| Recruiting |
NCT06186804 -
A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
|
Phase 2 | |
| Not yet recruiting |
NCT06458127 -
Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease
|
N/A | |
| Recruiting |
NCT06244628 -
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
|
Phase 3 | |
| Withdrawn |
NCT05604742 -
Belimumab for Treatment of cGVHD Following Allo-HCT
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05214066 -
Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
|
Phase 2 | |
| Recruiting |
NCT05919511 -
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
|